Cargando…
Screening of potential novel candidate genes in schwannomatosis patients
Schwannomatosis comprises a group of hereditary tumor predisposition syndromes characterized by, usually benign, multiple nerve sheath tumors, which frequently cause severe pain that does not typically respond to drug treatments. The most common schwannomatosis‐associated gene is NF2, but SMARCB1 an...
Autores principales: | Perez‐Becerril, Cristina, Wallace, Andrew J., Schlecht, Helene, Bowers, Naomi L., Smith, Philip T., Gokhale, Carolyn, Eaton, Helen, Charlton, Chris, Robinson, Rachel, Charlton, Ruth S., Evans, D. Gareth, Smith, Miriam J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540472/ https://www.ncbi.nlm.nih.gov/pubmed/35723634 http://dx.doi.org/10.1002/humu.24424 |
Ejemplares similares
-
Comparison of the frequency of loss‐of‐function LZTR1 variants between schwannomatosis patients and the general population
por: Deng, Fanxuan, et al.
Publicado: (2022) -
Pain correlates with germline mutation in schwannomatosis
por: Jordan, Justin T., et al.
Publicado: (2018) -
Scrambler Therapy for the Treatment of Pain in Schwannomatosis
por: Murphy, Tyler, et al.
Publicado: (2022) -
The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis
por: Gregory, Grace E, et al.
Publicado: (2023) -
Polyradiculopathies from Schwannomatosis
por: Jia, Yuxia, et al.
Publicado: (2011)